Short-Term Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 2 Diabetes Mellitus in Spain

Abstract

A343infant in comparison to no-screening strategy. Transferred to the entire birth cohort newborn screening is able to reduce total costs by 14 million € from the Austrian health care systems perspective each year. ConClusions: Funding the new-born screening saves money and is cost-effective for the Austrian health care system.